Avanza Fonder Ab Dexcom Inc Transaction History
Avanza Fonder Ab
- $3.86 Trillion
- Q3 2025
A detailed history of Avanza Fonder Ab transactions in Dexcom Inc stock. As of the latest transaction made, Avanza Fonder Ab holds 44,372 shares of DXCM stock, worth $2.58 Million. This represents 0.08% of its overall portfolio holdings.
Number of Shares
44,372
Previous 44,336
0.08%
Holding current value
$2.58 Million
Previous $3.87 Billion
22.85%
% of portfolio
0.08%
Previous 0.11%
Shares
4 transactions
Others Institutions Holding DXCM
# of Institutions
1,086Shares Held
376MCall Options Held
6.76MPut Options Held
7.24M-
Vanguard Group Inc Valley Forge, PA49.5MShares$2.87 Billion0.05% of portfolio
-
Black Rock Inc. New York, NY34.5MShares$2 Billion0.09% of portfolio
-
State Street Corp Boston, MA16.9MShares$979 Million0.04% of portfolio
-
Baillie Gifford & CO15.9MShares$922 Million0.84% of portfolio
-
Geode Capital Management, LLC Boston, MA11MShares$637 Million0.05% of portfolio
About DEXCOM INC
- Ticker DXCM
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 386,257,984
- Market Cap $22.4B
- Description
- DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...